The production of biologics, such as antibody drugs, is a complex, lengthy and costly process. Managing biologics manufacturing has been a great challenge to biotech companies, and most of them rely on contract manufacturing to fulfill the need.
At Alphamab Oncology, we have established our own cGMP production facilities to address the manufacturing issues which have plagued many biotech companies in developing biotherapeutics. Our team has over 10 years’ experience in successfully implementing and managing the CMC of multiple biologics projects, including bispecific antibody and complex fusion protein. We have already started manufacturing at our new state-of-the-art facility with advanced large-scale capabilities.
This enables us to scale up rapidly and have complete control of the manufacturing process. We can also ensure quality and timely supply of our biologics products, a key and valuable competence for the success of a biotech company.